Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term evaluation of stromal vascular fraction injection for eye contour rejuvenation
IRCT20220808055641N5Phase 2Completed
- Sponsor
- Vice Chancellor for Research of Tehran University of Medical Sciences
- Start
- Feb 2024
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of autologous adipose stromal vascular fraction in infraorbital hyperchromia (2 arms), sponsored by Vice Chancellor for Research of Tehran University of Medical Sciences. Started Feb 2024; status: completed.
02
Drugs
autologous adipose stromal vascular fraction
03
Conditions
infraorbital hyperchromia
Beyond the preview
Go deeper on IRCT20220808055641N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220808055641N5.